Two-Year Clinical Outcomes and Survivorship After Isolated Biceps Tenodesis

Purpose: The purpose of this study was to evaluate clinical outcomes and survivorship of isolated biceps tenodesis (BT) at a minimum of 2 years and to identify patient-specific factors associated with these outcomes in patients undergoing BT without concomitant rotator cuff repair (RCR). We hypothesized that patient-reported outcomes would be significantly improved on American Shoulder and Elbow Surgeons Survey (ASES) and Single Assessment Numeric Evalu-ation (SANE), with a high rate of survivorship (> 90%) at 2-year follow-up. Methods: A retrospective review of an institutional registry was performed to identify patients who underwent BT from July 2016 to December 2017. Patients > 18 years old who underwent an open or arthroscopic BT procedure using an interference screw, button, or anchor for underlying bicipital pathology, without a concomitant RCR or shoulder arthroplasty, and were a minimum of 2 years postoperative were included. Patients were administered ASES and SANE questionnaires preoperatively and at final follow-up. Survivorship was evaluated using Kaplan-Meier analysis. Failure was defined as any patient who underwent reoperation related to the index surgery. Results: A total of 110 patients (mean +/- standard deviation age, 48.60 +/- 12.14 years) who underwent isolated BT with a follow-up of 24.90 +/- 3.95 months were included in analysis. There was a significant improvement in ASES and SANE at final follow-up (P < .001), with 81% to 84% of patients achieving minimal clinically important difference (MCID), 72% to 82% achieving substantial clinical benefit (SCB), and 72% to 80% achieving patient-acceptable symptom state (PASS). Worker's Compensation (WC) patients had a decreased likelihood of achieving PASS on ASES (P = .015) and SANE (P = .012). Four cases were deemed failures (3 revision BTs and 1 capsular debridement) at 15.09 +/- 9.57 months. WC did not have a significant effect on likelihood of BT failure. onclusion: Biceps tenodesis provided significant clinical improvement and high rates of survivorship 2 years post-operatively. WC was associated with a decreased likelihood of achieving PASS. These results support the continued use of isolated BT for treating biceps pathology.

Automated summary

The purpose of this study was to evaluate the clinical outcomes and survivorship of isolated biceps tenodesis (BT) at a minimum of 2 years, and to identify patient-specific factors associated with these outcomes. The results showed that BT provided significant clinical improvement and high rates of survivorship at 2 years post-operatively. However, Workers' Compensation patients had a decreased likelihood of achieving patient-acceptable symptom state (PASS).